Samsung Medical Center

Area & Setting: Hospital · transplantation · Editorial Review: Updated 20 October 2026 · 3 minute read · Visit international website ↗

Clinical focus and team structure

Samsung Medical Center’s Hematologic Malignancy Center treats conditions including acute and chronic leukemia, lymphoma, multiple myeloma, light chain amyloidosis, aplastic anemia, and myelodysplastic syndrome. Its published approach brings together hematology with laboratory medicine, pathology, radiology, nuclear medicine, the blood bank, and radiation oncology.

The center describes hematopoietic stem cell transplantation and CAR-T treatment within its blood-disorder services. These procedures have different purposes and eligibility requirements. A consultation should establish which approach, if any, is relevant to the patient’s diagnosis and treatment history, rather than treating all cellular therapies as interchangeable.

The transplant program

The hospital dates its first hematopoietic stem cell transplant to 1996. It describes a transplant ward, a cell therapy unit, and a multidisciplinary care team that includes hematologic oncologists, transplant coordinators, specialist nurses, clinical pharmacists, and dietitians. The center also participates in clinical trials, including early-phase studies.

A trial program is an opportunity to discuss research options, not a promise of access or benefit. Ask whether any proposed option is routine clinical care or research, what eligibility rules apply, and how its risks and goals differ from other available treatments.

Follow-up after hospital discharge

Samsung’s Ambulatory Treatment Center houses a Stem Cell Transplantation Clinic for people discharged after hematopoietic stem cell transplantation. The hospital describes follow-up assessment, patient education, symptom management, and monitoring for complications and side effects. Its team also provides guidance on nutrition, daily habits, and self-care during longer-term recovery.

The wider ambulatory center provides cancer-related outpatient services such as infusions, transfusions, and selected procedures in coordination with hematology-oncology. The fact that some outpatient services are provided on the same day does not establish how long a transplant patient should remain in Korea. That timing must come from the individual treating team.

Access for international patients

The International Healthcare Center serves international patients and coordinates referrals to Samsung’s specialty services. Its website also describes video consultations for overseas patients following medical-team evaluation, including the possibility of involving local doctors. Availability and suitability should be confirmed directly for the individual case.

When making an enquiry, identify the diagnosis, treatment already received, and the decision you need help with. Ask whether the hematology team wants pathology material, imaging, prior chemotherapy information, donor-testing results, or other records before scheduling. Agree on a secure submission method rather than sending sensitive records to an unverified address.

Preparing for a meaningful comparison

These questions can make a hospital consultation more useful: What is the objective of transplant in my specific condition? How does the plan account for prior treatment and current response? Which donor or cell-source options are relevant? What alternatives could reasonably be considered now? Ask for explanations of benefits and uncertainties in language you understand.

For travel planning, request the expected sequence of assessment, treatment, inpatient care, and outpatient monitoring. Discuss whether a caregiver should remain nearby, how urgent symptoms will be assessed, and when a return journey might become medically reasonable. Obtain an itemized financial estimate and ask which additional costs could arise if care is prolonged.

Before leaving Korea, arrange the records and monitoring instructions needed by your home clinician. A clear transition plan should name who will review results, manage medicines, and answer questions after your return.

Sources & further reading

• Samsung Medical Center — Hematologic Malignancy Center (https://www.samsunghospital.com/en/cancer-center/hematologic-malignancy-center.do)
• Samsung Medical Center — Ambulatory Treatment Center (https://www.samsunghospital.com/en/cancer-center/ambulatory-treatment-center.do)
• Samsung Medical Center — International Healthcare Center (https://www.samsunghospital.com/en/international-healthcare-center.do)

Read alongside your treating specialist’s advice. Clinical eligibility, exact products and treatment plans require individual assessment.